Oct 2026· Antioxidants and Redox Signaling· pp.
15230864261501810
· 0 citations· 47 references
Medicine
TL;DR
These findings support a model in which tubular DMT1 integrates iron overload, ferroptotic stress, and TGF-β1-Smad signaling during fibrotic progression in CKD, and may offer a tubular-selective therapeutic strategy for CKD.
Abstract
INTRODUCTION
Renal fibrosis is a common pathological feature of chronic kidney disease (CKD), but effective therapies are still lacking. Ferroptosis has been increasingly associated with CKD; however, the iron-handling proteins that link ferroptotic stress to fibrotic signaling remain poorly defined. Here, we identify the divalent metal transporter 1 (DMT1) as a previously unrecognized regulatory factor that integrates iron metabolism, ferroptotic stress, and transforming growth factor-beta (TGF-β) signaling in tubular epithelial cells (TECs).
Results
DMT1 expression was elevated in TECs from folic acid injection- or unilateral ureteral obstruction-induced mouse CKD models and in isolated primary TECs exposed to TGF-β1 or palmitic acid, accompanied by increased mitochondrial reactive oxygen species (mtROS) production. Pharmacological inhibition or genetic deletion of DMT1 in TECs significantly attenuated renal fibrosis, with reduced renal fibrosis area, decreased expression of profibrotic genes and markers, lower mtROS production, and restored fatty acid oxidation. DMT1 deficiency also attenuated lipid peroxidation, with reduced 4-HNE levels and lipid droplet deposition in mouse CKD models. Additionally, DMT1 deletion reduced tissue iron content, reversed ferroptosis-associated morphological changes in TECs, and restored tissue glutathione peroxidase-4 expression. Notably, DMT1 deletion reduced both total Smad2 and phosphorylated Smad2 induced by TGF-β1, consistent with suppression of the TGF-β1-Smad axis.
INNOVATION AND
Conclusions
These findings support a model in which tubular DMT1 integrates iron overload, ferroptotic stress, and TGF-β1-Smad signaling during fibrotic progression in CKD. DMT1 functions as a signaling hub contributing to TGF-β1-Smad axis activation, although a direct causal chain from iron influx to transforming growth factor beta receptor 1 induction remains to be fully delineated. DMT1 inhibition may offer a tubular-selective therapeutic strategy for CKD. Antioxid. Redox Signal. 00, 000-000.
Findings reveal SRPX2 as a key pathogenic factor driving renal fibrosis by disrupting tubular iron homeostasis and Targeting the SRPX2-IRP1 regulatory axis presents a promising therapeutic strategy for slowing CKD progression.
Pei-Ran Yin, Lu-Miao Chen, M. Ding et al.· Cell Death and Differentiati...· 0 citations
It is demonstrated that GMN attenuates renal inflammation, suppresses myofibroblast activation and ECM remodeling by concurrently inhibiting NF-κB/NLRP3 inflammasome axis and TGF-β1/Smad pathway.
Shobhit Gairola, A. Bhatta, Tushar Mishra et al.· Phytotherapy Research· 0 citations
In a unilateral ureteral obstruction-induced CKD mouse model, QCT treatment attenuated tubular injury, improved renal function, and reduced fibrosis markers such as fibronectin, Col1a1, and α-SMA.
HMGN5 is identified as a novel regulator of IFNAR2-related pyroptosis-associated signaling in renal tubular epithelial cells and it is suggested that the HMGN5-IFNAR2 axis represents a pathophysiological pathway of interest in CKD that warrants further investigation.
Xue Rong, Jing Xu, Jie-Nan Zhang et al.· International Journal of Mol...· 0 citations
It is shown that deleting Pdcd10, specifically in distal nephron epithelial cells of mice, causes a rapid intrinsic injury response that precipitates chronic renal damage, and that PDCD10-STK24/25 signaling is essential for maintaining renal epithelial cell homeostasis.
Yi-Xuan Wang, Xi Yang, Min Zheng et al.· The FEBS Journal· 0 citations
Abstract Peritoneal fibrosis, a major complication of long-term peritoneal dialysis, is driven by transforming growth factor-β1 (TGF-β1)-mediated mesothelial cell dysfunction. Emerging evidence links ferroptosis—a lipid peroxidation-dependent cell death—to fibrotic diseases, but the molecular mechanisms in peritoneal p...